Suppr超能文献

人肝癌衍生细胞系HepG2的补体生物合成

Complement biosynthesis by the human hepatoma-derived cell line HepG2.

作者信息

Morris K M, Aden D P, Knowles B B, Colten H R

出版信息

J Clin Invest. 1982 Oct;70(4):906-13. doi: 10.1172/jci110687.

Abstract

The human hepatoma-derived cell line, HepG2, synthesized and secreted functional complement proteins C1r, C1s, C2, C3, C4, C5, factor B, C1 inhibitor, C3b inactivator, a small amount of C6, and trace amounts of C8; but failed to produce detectable C1q, C7, or C9. Immunochemically, C2, C3, C4, C5, and B were isolated from culture medium as proteins with molecular sizes and subunit structures identical to the corresponding components isolated from serum. C2 and factor B from cellular lysates had slightly lower molecular weights than the corresponding proteins in culture medium. C3, C4, and C5 were detected as single chain precursor molecules in cellular lysates. These results demonstrate that human C5, like C3 and C4, is synthesized as a single chain precursor that is converted by limited proteolysis to the native two-chain molecule. It also establishes the precursor-product relationship for human pro-C4 and native C4, pro-C5, and native C5.

摘要

人肝癌衍生细胞系HepG2能合成并分泌功能性补体蛋白C1r、C1s、C2、C3、C4、C5、B因子、C1抑制剂、C3b灭活剂、少量C6和微量C8;但未能产生可检测到的C1q、C7或C9。免疫化学分析表明,从培养基中分离出的C2、C3、C4、C5和B蛋白,其分子大小和亚基结构与从血清中分离出的相应成分相同。细胞裂解物中的C2和B因子分子量略低于培养基中的相应蛋白。在细胞裂解物中检测到C3、C4和C5为单链前体分子。这些结果表明,人C5与C3和C4一样,是以单链前体形式合成的,通过有限的蛋白水解作用转化为天然的双链分子。这也确立了人C4前体与天然C4、C5前体与天然C5之间的前体-产物关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca6/370299/054edab8c809/jcinvest00704-0222-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验